Medicines shortages in the EU: strategies to prevent and mitigate their impact

The presentation explores how the European institution approach to medicine shortages has evolved, culminating in the Critical Medicines Act. It considers how EU initiatives are redefining oversight, and coordination across the supply chain. Particular emphasis is placed on emerging incentives and policy measures designed to sustain the availability of medicines on the EU market. A dedicated focus is given to medicines included in the EU List of Critical Medicines and the implications for ensuring their long-term supply continuity across Member States.